Document Detail


Oral beclomethasone dipropionate for treatment of intestinal graft-versus-host disease: a randomized, controlled trial.
MedLine Citation:
PMID:  9649455     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND & AIMS: Beclomethasone dipropionate (BDP), a topically active steroid, seemed to be an effective treatment for intestinal graft-versus-host disease (GVHD) in a phase I study. The aim of this study was to compare the effectiveness of oral BDP to that of placebo capsules in treatment of intestinal GVHD. METHODS: Sixty patients with anorexia and poor oral intake because of intestinal GVHD were randomized to receive prednisone (1 mg.kg-1.day-1) plus either oral BDP (8 mg/day) or placebo capsules. Initial responders who were eating at least 70% of caloric needs at evaluation on day 10 continued to take study capsules for an additional 20 days while the prednisone dose was rapidly tapered. The primary end point was the frequency of a durable treatment response at day 30 of treatment. RESULTS: The initial treatment response at day 10 was 22 of 31 (71%) in the BDP/prednisone group vs. 16 of 29 (55%) for the placebo/prednisone group. The durable treatment response at day 30 was 22 of 31 (71%) vs. 12 of 29 (41%), respectively (P = 0.02). CONCLUSIONS: The combination of oral BDP capsules and prednisone was more effective than prednisone alone in treating intestinal GVHD. Oral BDP allowed prednisone doses to be rapidly tapered without recurrent intestinal symptoms.
Authors:
G B McDonald; M Bouvier; D M Hockenbery; J M Stern; T Gooley; A Farrand; C Murakami; D S Levine
Related Documents :
7596005 - Periodic treatment regimens with inhaled steroids in asthma or chronic obstructive pulm...
8080385 - Effect of high-dose intravenous immunoglobulin on amyotrophic lateral sclerosis and mul...
668445 - Corticosteroids in radiation-induced pericarditis.
17315055 - Treatment persistence and compliance with medications for chronic obstructive pulmonary...
8686825 - Postoperative cognitive impairment in the elderly. choice of patient-controlled analges...
10476895 - The effect of postsurgical antibiotics and a bioabsorbable membrane on regenerative hea...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Gastroenterology     Volume:  115     ISSN:  0016-5085     ISO Abbreviation:  Gastroenterology     Publication Date:  1998 Jul 
Date Detail:
Created Date:  1998-07-23     Completed Date:  1998-07-23     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0374630     Medline TA:  Gastroenterology     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  28-35     Citation Subset:  AIM; IM    
Affiliation:
Gastroenterology/Hepatology Section, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Oral
Adult
Aged
Beclomethasone / administration & dosage,  adverse effects,  therapeutic use*
Female
Graft vs Host Disease / drug therapy*
Humans
Inflammatory Bowel Diseases / drug therapy*
Male
Middle Aged
Prednisone / therapeutic use
Grant Support
ID/Acronym/Agency:
CA-15704/CA/NCI NIH HHS; CA-18029/CA/NCI NIH HHS; FD-R-000827/FD/FDA HHS
Chemical
Reg. No./Substance:
4419-39-0/Beclomethasone; 53-03-2/Prednisone
Comments/Corrections
Comment In:
Gastroenterology. 1998 Jul;115(1):220-2   [PMID:  9649479 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Anti-p53 antibodies in patients with Barrett's esophagus or esophageal carcinoma can predate cancer ...
Next Document:  Effect of a low-impact exercise program on bone mineral density in Crohn's disease: a randomized con...